227 related articles for article (PubMed ID: 20127571)
1. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
Saeger W
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
[No Abstract] [Full Text] [Related]
2. Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia.
Haap M; Gallwitz B; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):289-93. PubMed ID: 19085700
[TBL] [Abstract][Full Text] [Related]
3. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
5. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
6. P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease.
Kawashima ST; Usui T; Sano T; Iogawa H; Hagiwara H; Tamanaha T; Tagami T; Naruse M; Hojo M; Takahashi JA; Shimatsu A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):656-7. PubMed ID: 18771563
[No Abstract] [Full Text] [Related]
7. Silent or Subclinical Corticotroph Pituitary Macroadenoma Transforming Into Cushing Disease: 11-Year Follow-up.
Melcescu E; Gannon AW; Parent AD; Fratkin JF; Nicholas WC; Koch CA; Galhom A
Neurosurgery; 2013 Jan; 72(1):E144-6. PubMed ID: 23037824
[No Abstract] [Full Text] [Related]
8. Reversible "brain atrophy" in patients with Cushing's disease.
Gnjidić Z; Sajko T; Kudelić N; Malenica M; Vizner B; Vrkljan M; Hat J; Rumboldt Z
Coll Antropol; 2008 Dec; 32(4):1165-70. PubMed ID: 19149224
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
[TBL] [Abstract][Full Text] [Related]
10. Invasion of the corticotrophs.
Mayberg MR
J Neurosurg; 2012 Feb; 116(2):269-71; discussion 270-1. PubMed ID: 21923245
[No Abstract] [Full Text] [Related]
11. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of preoperative magnetic resonance imaging of the pituitary for surgical cure in Cushing's disease.
Witek P; Zielinski G
Turk Neurosurg; 2012; 22(6):747-52. PubMed ID: 23208907
[TBL] [Abstract][Full Text] [Related]
14. Silent corticotroph adenoma.
Rajesh A
Neurosurgery; 2013 Jul; 73(1):E191-2. PubMed ID: 23615102
[No Abstract] [Full Text] [Related]
15. Current status on histological classification in Cushing's disease.
Syro LV; Rotondo F; Cusimano MD; Di Ieva A; Horvath E; Restrepo LM; Wong M; Killinger DW; Smyth H; Kovacs K
Pituitary; 2015 Apr; 18(2):217-24. PubMed ID: 25501318
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of corticotroph adenoma and thyrotroph hyperplasia in a dog.
Teshima T; Hara Y; Shigihara K; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
J Vet Med Sci; 2009 Jan; 71(1):93-8. PubMed ID: 19194082
[TBL] [Abstract][Full Text] [Related]
17. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
[TBL] [Abstract][Full Text] [Related]
18. Co-existence of pituicytoma and corticotroph adenoma in a patient with Cushing's disease.
Wee Z; Tang PY; Lai SH; Ang BT; Chandran SR
Pathology; 2023 Apr; 55(3):432-435. PubMed ID: 36351865
[No Abstract] [Full Text] [Related]
19. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]